Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and PK of Oxantel Pamoate in healthy volunteers
NCT06606860Phase 1Completed
- Sponsor
- Swiss Tropical and Public Health Institute
- Start
- Jan 2025
- Primary completion
- Apr 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of oxantel in trichuriasis (3 arms), sponsored by Swiss Tropical and Public Health Institute. Primary endpoints: General safety (number, frequency, severity, seriousness and duration of adverse events), Heart rate from baseline and 4 more. Started Jan 2025; status: completed.
02
Drugs
oxantel
03
Conditions
trichuriasis
Beyond the preview
Go deeper on NCT06606860.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06606860.